Media coverage
2
Media coverage
Title Press Release: Dupixent® (Dupilumab) Late-Breaking Phase 3 Data Presented At UEG Week 2022 Showed Significant Histological Remission Of Eosinophilic Esophagitis (Eoe) In Children 1 To 11 Years Old Media name/outlet MENAFN -Press Releases (English) Country/Territory Jordan Date 11/10/22 Persons Mirna Chehade Title Dupixent® (Dupilumab) Late-Breaking Phase 3 Data Presented At UEG Week 2022 Showed Significant Histological Remission Of Eosinophilic Esophagitis (Eoe) In Children 1 To 11 Years Old' Media name/outlet MENAFN -Press Releases (English) Country/Territory Jordan Date 11/10/22 Persons Mirna Chehade